The New insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes-Reference-Cited by-同舟云学术

The New insights from DPP-4 inhibitors: their potential immune modulatory function in autoimmune diabetes

Published:2014-11 Issue:8 Volume:30 Page:646-653
ISSN:1520-7552
Container-title:Diabetes/Metabolism Research and Reviews
language:en
Short-container-title:Diabetes Metab Res Rev

Author:

Zhao Yunjuan¹,Yang Lin¹,Wang Xiangbing²,Zhou Zhiguang¹

Affiliation:

1. Diabetes Center, Institute of Metabolism and Endocrinology, The Second Xiangya Hospital and Key Laboratory of Diabetes Immunology, Ministry of Education; Central South University; Changsha China

2. Division of Endocrinology, Metabolism and Nutrition; Rutgers University-Robert Wood Johnson Medical School; New Brunswick NJ USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmrr.2530/fullpdf

Reference89 articles.

1. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

2. Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes;Mari;J Clin Endocrinol Metab,2005

3. Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: results from two randomized, double-blind, placebo-controlled studies with single oral doses;Herman;Clin Pharmacol Ther,2005

4. Effect of single oral doses of sitagliptin, a dipeptidyl peptidase-4 inhibitor, on incretin and plasma glucose levels after an oral glucose tolerance test in patients with type 2 diabetes;Herman;J Clin Endocrinol Metab,2006

5. Effects of the dipeptidyl peptidase-IV inhibitor vildagliptin on incretin hormones, islet function, and postprandial glycemia in subjects with impaired glucose tolerance;Rosenstock;Diabetes Care,2008

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DPP2/7 is a Potential Predictor of Prognosis and Target in Immunotherapy in Colorectal Cancer: An Integrative Multi-omics Analysis;Combinatorial Chemistry & High Throughput Screening;2024-07

2. Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: A 12‐month, randomized, comparator‐controlled pilot study;Diabetes, Obesity and Metabolism;2024-01-31

3. The effect of gemigliptin treatment on immune parameters including regulatory T cells in patients with type 2 diabetes and moderate to very severe chronic renal impairment;Medicine;2023-12-08

4. Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus;Journal of Infection and Public Health;2023-11

5. Immunomodulatory activity of dipeptidyl peptidase‐4 inhibitors in immune‐related diseases;European Journal of Immunology;2023-09-28